AI-generated summary
The authors studied whether low-level laser therapy applied to bone marrow could stimulate mesenchymal stem cells and affect memory and amyloid burden in a mouse model of Alzheimer's disease. They report that weekly treatment for two months in mice at a progressive disease stage improved cognitive capacity and spatial learning compared with sham-treated mice, with reduced brain amyloid-beta burden on histology. The work was conducted in mice and cells, so its relevance to humans is not established.
- Who or what was studied
- Mouse model of Alzheimer's disease (AD) at a progressive stage, starting at 4 months of age, and wild-type mice for cell studies
- Limits stated in the abstract
- The study was conducted in mice and cells, and the abstract does not report the number of animals or any human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Light-emitting diode, Inflammation, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.